EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudieOpen Access · CC BY 4.0

A risk stratification model for high-flow nasal cannula use in patients with coronavirus disease 2019 in Japan: A single-center retrospective observational cohort study

Ibuki Kurihara iD, Hitoshi Sugawara iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0290937 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift PLOS ONE, 2024. Verfasst von Ibuki Kurihara und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Medicine, Department of Comprehensive Medicine 1, Saitama Medical Center, Jichi Medical University, Saitama City, Saitama, Japan. Hauptthemen laut MEDLINE: COVID-19, Respiratory Insufficiency. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The coronavirus disease 2019 (COVID-19) pandemic has put a strain on the healthcare system, and sudden changes in disease status during home treatment have become a serious issue. Therefore, prediction of disease severity and allocation of sufficient medical resources, including high-flow nasal cannula (HFNC), to patients in need are important. We aimed to determine risk factors for the need of HFNC use in COVID-19.

Methods

This was a single-center retrospective observational cohort study including all eligible hospitalized adult patients aged ≥18 years diagnosed with COVID-19 between April 14, 2020 and August 5, 2021 who were treated in the study hospital. The primary outcome is the need for HFNC. Nineteen potential predictive variables, including patient characteristics at hospital admission, were screened using least absolute shrinkage and selection operator and logistic regression to construct a predictive risk score. Accuracy of the risk score was determined using area under the receiver operating characteristic curve.

Results

The study cohort included 148 patients. The rate of the need for HFNC was 22.9%. Among the 19 potential variables, percutaneous oxygen saturation (SpO 2 )

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Respiratory InsufficiencyAdultHumansAdolescentCannulaRetrospective StudiesJapanRisk AssessmentOxygen Inhalation TherapyOxygen

Substanzen

Oxygen

Autor:innen und Institutionen

  • Division of General Medicine, Department of Comprehensive Medicine 1, Saitama Medical Center, Jichi Medical University, Saitama City, Saitama, Japan.

ORCID-Profile: Ibuki Kurihara, Hitoshi Sugawara

Zitieren

APA

Kurihara, I., & Sugawara, H. (2024). A risk stratification model for high-flow nasal cannula use in patients with coronavirus disease 2019 in Japan: A single-center retrospective observational cohort study. PLOS ONE. https://doi.org/10.1371/journal.pone.0290937

Vancouver

Kurihara I, Sugawara H. A risk stratification model for high-flow nasal cannula use in patients with coronavirus disease 2019 in Japan: A single-center retrospective observational cohort study. PLOS ONE. 2024. doi:10.1371/journal.pone.0290937

BibTeX
@article{Kurihara2024,
  author = {Kurihara, Ibuki and Sugawara, Hitoshi},
  title = {A risk stratification model for high-flow nasal cannula use in patients with coronavirus disease 2019 in Japan: A single-center retrospective observational cohort study},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0290937}
}
Kostenlos starten →